2-(1H-indol-3-yl)-N,N-dimethylethanamine;2-(1H-indol-3-yl)-N,N-dimethyl-ethanamine;2-(1H-indol-3-yl)ethyl-dimethyl-amine;68677-25-8;61-50-7;2-(1H-indol-3-yl)-N,N-dimethylethanamine;InChI=1/C12H16N2/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12/h3-6,9,13H,7-8H2,1-2H;DIMETHYLTRYPTAMINE;Indole, 3-[2-(dimethylamino)ethyl]-;NSC63795;DEA No. 7435;(2-Indol-3-ylethyl)dimethylamine;AIDS-072305;AIDS072305;C08302;N,N-Dimethyltryptamine;1H-Indole-3-ethanamine, N,N-dimethyl-;2-(3-Indolyl)ethyldimethylamine;3-(2-Dimethylaminoethyl)indole;1H-Indole-3-ethanamine, N,N-dimethyl- (9CI);5-22-10-00048 (Beilstein Handbook Reference);BRN 0138259;WLN: T56 BMJ D2N1&1;DMT (psychogenic);EINECS 200-508-4;Indole, 3-(2-(dimethylamino)ethyl)-;N,N-Dimethyl-1H-indole-3-ethylamine;NSC 63795
2-(1H-indol-3-yl)-N,N-dimethylethanamine